DGX is poised for solid Q3 2025 results, backed by strong DIS growth, strategic M&A and robust test demand across key health segments.

Quest Diagnostics can benefit from continued demand for specific diagnostic testing across a broad range of clinical areas.

A cancer treatment laboratory in Lewisville recently made a medical breakthrough that could greatly decrease the risk of the ...

Blood test to aid cancer treatment and recurrence monitoring now available from a German lab for potentially faster results ...

Epic will partner with Quest on Project Nova, a multi-year effort to streamline and enhance customer-facing processes for patients and providers across all EHR platforms. The implementation will ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Quest Diagnostics (DGX) reports results for ...

Quest Diagnostics Inc raised its full-year earnings expectations on Thursday after a strong quarterly beat and forecast robust demand for COVID-19 tests during the fall season and into 2021.

Implementation will enable users to purchase, schedule appointments for testing, and receive results of lab tests performed by Quest within the WHOOP app, supporting access to deeper health and ...

One thing I really noticed about Everlywell is how woman-centered it felt. Many health platforms can feel ...

According to WSJ, Dr. Tom Delbanco, a primary-care expert at Harvard Medical School, said that “the more a patient gets ...

Finnish health tech company Oura has raised $900 million in fresh funding led by Fidelity Management & Research Company, with ...